Status:
RECRUITING
A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
Lead Sponsor:
The Third Xiangya Hospital of Central South University
Collaborating Sponsors:
Changsha Hospital for Maternal and Child Health Care
ZhuZhou Central Hospital
Conditions:
Retained Products of Conception
RPOC
Eligibility:
FEMALE
18-45 years
Brief Summary
The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant manag...
Eligibility Criteria
Inclusion Criteria:Clinical diagnosis of retained products of conception, and ultrasound indicated that the maximum diameter of the lesion ≥0.5cm.
Exclusion Criteria:1) There is active bleeding requiring immediate surgical intervention;2) combined with obvious infection;3) Combined with severe organ dysfunction, including coagulation dysfunction.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07421895
Start Date
June 1 2022
End Date
December 31 2032
Last Update
February 19 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China, 410013